1.
2.
Strength persists after a mid-life course of obesity drugs
(feeds.nature.com)
4.
Why smaller portions are the biggest restaurant trend right now
(feeds.feedburner.com)
5.
‘Musclezempic’ Could Be the Future of Weight Loss
(gizmodo.com)
6.
Are obesity drugs causing a severe complication? What the science says
(feeds.nature.com)
9.
This Founder Is Taking a Bite Out of the $50 Billion GLP-1 Market By Going Natural
(feeds.feedburner.com)
10.
Can Ozempic Cure Addiction?
(news.ycombinator.com)
11.
Hims & Hers is scrapping its plan for a knockoff Wegovy weight-loss pill. Here’s why
(feeds.feedburner.com)
12.
GLP-1s Are an Environmental Catastrophe
(futurism.com)
13.
FDA intends to take action against non-FDA-approved GLP-1 drugs
(news.ycombinator.com)
14.
White House launches direct-to-consumer drug site TrumpRx
(news.ycombinator.com)
15.
Novo Nordisk Furious at $49 Knockoff Ozempic Pill
(futurism.com)
16.
Why Cops Frequently Got Caught Planting Drugs in 2017
(gizmodo.com)
17.
18.
19.
ADHD treatments move beyond stimulants
(feeds.nature.com)
20.
Untangling the connection between dopamine and ADHD
(feeds.nature.com)
21.
ADHD is on the rise, but why?
(feeds.nature.com)
22.
This Is How GLP-1 Drugs Are Forcing Restaurant Chains to Change Their Menus
(feeds.feedburner.com)
23.
24.
Ozempic is changing the foods Americans buy
(news.ycombinator.com)
25.
Ozempic reduced grocery spending by an average of 5.3% in the US
(news.ycombinator.com)
26.
27.
Something Grim Is Happening to People Who Go Off GLP-1s
(futurism.com)
28.
Tips from pharmacists to lower your out-of-pocket drug costs
(feeds.feedburner.com)
29.
People Jabbing Themselves With Black Market “GLP-3” Drugs
(futurism.com)
30.
Today's top topics:
meta
google
openai
amazon
child safety
new mexico
daredevil
android
social media
samsung